Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
Monia Ezzalfani, Lead Consultant and Practice Advisor – Biostatistics and HEOR Amaris Consulting, shared a post on LinkedIn:
“Our new publication: ‘Patient Preferences for the Treatment of Haemophilia A and B in France.’
Developed in collaboration with Pfizer, this study addresses the growing need to embed patient preferences in therapeutic assessments.
It shows how French patients with haemophilia prioritize key treatment attributes, providing actionable insights for clinical and regulatory decision‑making.”
Title: Patient Preferences for the Treatment of Haemophilia A and B in France
Authors: Yesim Dargaud, Yasmine Fahfouhi, Monia Ezzalfani, Astrid Foix Colonier, Alaeddine Sidhom, Aline Gauthier, Jérémie Rudant, Meriem Kessouri, Nicolas Giraud, Benoît Guillet, Anaïs Reynaud
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?